CCFM
ICPT

Clear Creek Financial Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Clear Creek Financial Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,763
Closed -$178K – 316
2022
Q3 		$178K Hold
12,763
– – 0.04% 264
2022
Q2 		$176K Buy
+12,763
New +$204K 0.04% 285

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Clear Creek Financial Management's ICPT Position: Q4 2022 in Review

Clear Creek Financial Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2022, closing a stake of 12,763 shares — an estimated $178K sold.

Clear Creek Financial Management first reported a position in ICPT in Q2 2022 and held it in 2 quarters. The position peaked at $178K in Q3 2022. 144 funds tracked by Wall St. Rank hold ICPT as of Q4 2022.

  • Clear Creek Financial Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Clear Creek Financial Management sold 12,763 Intercept Pharmaceuticals, Inc. shares in Q4 2022, an estimated $178K.
  • Clear Creek Financial Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2022 and held it in 2 quarters.
  • Clear Creek Financial Management's Intercept Pharmaceuticals, Inc. position peaked at $178K in Q3 2022.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2022.

Based on Clear Creek Financial Management's 13F filing for Q4 2022, filed 24 Jan 2023.